Virginia Tech® home

Home

Insert your title here

 

Featured Story

Warren Bickel, Ph.D.

Oct. 2, 2024

In memoriam: Warren Bickel, professor and global pioneer in addiction recovery research

Warren Bickel, whose innovative approach to addiction research saved lives, inspired generations of scientists, and put him among the top 1 percent of the world most highly cited researchers, died Saturday, Sept. 28. He was 68.

In 2011, Bickel was among the first scientists to join Virginia Tech’s Fralin Biomedical Research Institute at VTC. There, he became the inaugural director of the institute’s Addiction Recovery Research Center and in 2016 was named director of its Center for Health Behaviors Research. His research helped pioneer buprenorphine treatment, one of only three Food and Drug Administration (FDA)-approved medications to treat opioid use disorder, which affects more than 40 million people worldwide.

Creating a healthier future. For everyone.

The Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class researchers. The institute’s Virginia Tech scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disorders, heart disease, and cancer. Since its founding in 2010, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also investing in brand-new laboratories on the Children’s National Research & Innovation Campus in Washington, D.C.

Loading player for https://video.vt.edu/media/Welcome+to+the+Fralin+Biomedical+Research+Institute/1_7bgzxc60...


VIDEOS
 


SEMINARS & EVENTS
 

Loading player for https://www.youtube.com/watch?v=Gec4l80mnNk...

Giving to the Research Institute

Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.